Inhibitor of protein kinase C (PKC) and cyclin-dependent kinases (CDKs) resulting in accumulation of cells in the G1 phase and induction of apoptosis. Enhances the cytotoxicity of other anticancer drugs, such as DNA-damaging agents and anti-metabolite drugs, through putative abrogation of G2 and/or S phase accumulation induced by these agents.
Catalogs / Brochures
E-Newsletter
Shopping Cart [0]
Distributors
Online Product Ordering
Clipboard [0]
Your items will be kept only for the duration of your visit.